Publications
Found 20 results
Filters: Author is X.Y. Liu [Clear All Filters]
“Association of MMP3 genotype with susceptibility to frozen shoulder: a case-control study in a Chinese Han population”, vol. 15, p. -, 2016.
, “Association of MMP3 genotype with susceptibility to frozen shoulder: a case-control study in a Chinese Han population”, vol. 15, p. -, 2016.
, “Association of MMP3 genotype with susceptibility to frozen shoulder: a case-control study in a Chinese Han population”, vol. 15, p. -, 2016.
, , , “Cloning and characterization of a farnesyl pyrophosphate synthase from Matricaria recutita L. and its upregulation by methyl jasmonate”, vol. 14, pp. 349-361, 2015.
, “imDC: an ensemble learning method for imbalanced classification with miRNA data”, vol. 14, pp. 123-133, 2015.
, “Inheritance of balanced translocation t(17; 22) from a Down syndrome mother to a phenotypically normal daughter”, vol. 14, pp. 10267-10272, 2015.
, “A novel frameshift deletion in the COL1A1 gene identified in a Chinese family with osteogenesis imperfecta”, vol. 14, pp. 15295-15300, 2015.
, “A rare PAX6 mutation in a Chinese family with congenital aniridia”, vol. 14, pp. 13328-13336, 2015.
, “Topological centrality-based identification of hub genes and pathways associated with acute viral respiratory infection in infants”, vol. 14, pp. 18334-18343, 2015.
, “Genetic characterization and authentication of Dimocarpus longan Lour. using an improved RAPD technique”, vol. 13, pp. 1447-1455, 2014.
, “Molecular cloning and characterization of the full-length Hsp90 gene from Matricaria recutita”, vol. 13, pp. 10994-11003, 2014.
, “A novel mutation of PAX6 identified in a Chinese twin family with congenital aniridia complicated with nystagmus”, vol. 13, pp. 8679-8685, 2014.
, “A novel NF1 frame-shift mutation (c.702_703delGT) in a Chinese family with neurofibromatosis type 1”, vol. 13, pp. 5395-5404, 2014.
, “Prevalence and risk factors of overweight and obesity among individuals over 40 years old in Luzhou city”, vol. 13, pp. 9262-9270, 2014.
, ,
“Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma”, vol. 11, pp. 3618-3628, 2012.
,
Bai J, Dai J, Yu H, Shen H, et al. (2009). Cigarette smoking, MDM2 SNP309, gene-environment interactions, and lung cancer risk: a meta-analysis. J. Toxicol. Environ. Health A 72: 677-682.
http://dx.doi.org/10.1080/15287390902840930
PMid:19492228
Begg CB and Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
http://dx.doi.org/10.2307/2533446
PMid:7786990
Biernat W, Kleihues P, Yonekawa Y and Ohgaki H (1997). Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J. Neuropathol. Exp. Neurol. 56: 180-185.
http://dx.doi.org/10.1097/00005072-199702000-00009
PMid:9034372
Bond GL, Hu W, Bond EE, Robins H, et al. (2004). A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119: 591-602.
http://dx.doi.org/10.1016/j.cell.2004.11.022
PMid:15550242
Bredel M, Scholtens DM, Yadav AK, Alvarez AA, et al. (2011). NFKBIA deletion in glioblastomas. N. Engl. J. Med. 364: 627-637.
http://dx.doi.org/10.1056/NEJMoa1006312
PMid:21175304
Dai S, Mao C, Jiang L, Wang G, et al. (2009). P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies. Hum. Genet. 125: 633-638.
http://dx.doi.org/10.1007/s00439-009-0664-3
PMid:19357867
DerSimonian R and Laird N (1986). Meta-analysis in clinical trials. Control Clin. Trials 7: 177-188.
http://dx.doi.org/10.1016/0197-2456(86)90046-2
Dumont P, Leu JI, Della Pietra AC, George DL, et al. (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat. Genet. 33: 357-365.
http://dx.doi.org/10.1038/ng1093
PMid:12567188
Egger M, Davey SG, Schneider M and Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
http://dx.doi.org/10.1136/bmj.315.7109.629
PMid:9310563 PMCid:2127453
El Hallani S, Marie Y, Idbaih A, Rodero M, et al. (2007). No association of MDM2 SNP309 with risk of glioblastoma and prognosis. J. Neurooncol. 85: 241-244.
http://dx.doi.org/10.1007/s11060-007-9416-1
PMid:17568997
El Hallani S, Ducray F, Idbaih A, Marie Y, et al. (2009). TP53 codon 72 polymorphism is associated with age at onset of glioblastoma. Neurology 72: 332-336.
http://dx.doi.org/10.1212/01.wnl.0000341277.74885.ec
PMid:19171829
Fang F, Yu XJ, Yu L and Yao L (2011). MDM2 309 T/G polymorphism is associated with colorectal cancer risk especially in Asians: a meta-analysis. Med. Oncol. 28: 981-985.
http://dx.doi.org/10.1007/s12032-010-9577-1
PMid:20503107
Gu J, Liu Y, Kyritsis AP and Bondy ML (2009). Molecular epidemiology of primary brain tumors. Neurotherapeutics 6: 427-435.
http://dx.doi.org/10.1016/j.nurt.2009.05.001
PMid:19560733
Haupt Y, Maya R, Kazaz A and Oren M (1997). Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
http://dx.doi.org/10.1038/387296a0
PMid:9153395
Hunter SB, Abbott K, Varma VA, Olson JJ, et al. (1995). Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. J. Neuropathol. Exp. Neurol. 54: 57-64.
http://dx.doi.org/10.1097/00005072-199501000-00007
PMid:7815080
Idbaih A, Boisselier B, Marie Y, Sanson M, et al. (2008). Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors. Brain Res. 1198: 16-20.
http://dx.doi.org/10.1016/j.brainres.2008.01.027
PMid:18262501
Jeong BS, Hu W, Belyi V, Rabadan R, et al. (2010). Differential levels of transcription of p53-regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis. FASEB J. 24: 1347-1353.
http://dx.doi.org/10.1096/fj.09-146001
PMid:20019240
Jha P, Jha P, Pathak P, Chosdol K, et al. (2011). TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3. Exp. Mol. Pathol. 90: 167-172.
http://dx.doi.org/10.1016/j.yexmp.2010.11.002
PMid:21115003
Khatri RG, Navaratne K and Weil RJ (2008). The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme. J. Neurosurg. 109: 842-848.
http://dx.doi.org/10.3171/JNS/2008/109/11/0842
PMid:18976073
Kubbutat MH, Jones SN and Vousden KH (1997). Regulation of p53 stability by Mdm2. Nature 387: 299-303.
http://dx.doi.org/10.1038/387299a0
PMid:9153396
Kussie PH, Gorina S, Marechal V, Elenbaas B, et al. (1996). Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274: 948-953.
http://dx.doi.org/10.1126/science.274.5289.948
PMid:8875929
Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, et al. (2008). TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Cancer Genet. Cytogenet. 180: 14-19.
http://dx.doi.org/10.1016/j.cancergencyto.2007.08.019
PMid:18068527
Liu L, Wang K, Zhu ZM and Shao JH (2011). Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis. Arch. Med. Res. 42: 60-69.
http://dx.doi.org/10.1016/j.arcmed.2011.01.008
PMid:21376265
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, et al. (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114: 97-109.
http://dx.doi.org/10.1007/s00401-007-0243-4
PMid:17618441 PMCid:1929165
Malmer B, Feychting M, Lonn S, Ahlbom A, et al. (2005). p53 Genotypes and risk of glioma and meningioma. Cancer Epidemiol. Biomarkers Prev. 14: 2220-2223.
http://dx.doi.org/10.1158/1055-9965.EPI-05-0234
PMid:16172235
Malmer BS, Feychting M, Lonn S, Lindstrom S, et al. (2007). Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma. J. Neurooncol. 82: 229-237.
http://dx.doi.org/10.1007/s11060-006-9275-1
PMid:17151932
Marin MC, Jost CA, Brooks LA, Irwin MS, et al. (2000). A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat. Genet. 25: 47-54.
http://dx.doi.org/10.1038/75586
PMid:10802655
Minelli C, Thompson JR, Abrams KR, Thakkinstian A, et al. (2008). How should we use information about HWE in the meta-analyses of genetic association studies? Int. J. Epidemiol. 37: 136-146.
http://dx.doi.org/10.1093/ije/dym234
PMid:18037675
Ohgaki H, Dessen P, Jourde B, Horstmann S, et al. (2004). Genetic pathways to glioblastoma: a population-based study. Cancer Res. 64: 6892-6899.
http://dx.doi.org/10.1158/0008-5472.CAN-04-1337
PMid:15466178
Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, et al. (1993). Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362: 857-860.
http://dx.doi.org/10.1038/362857a0
PMid:8479525
Parhar P, Ezer R, Shao Y, Allen JC, et al. (2005). Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas. Brain Res. Mol. Brain Res. 137: 98-103.
http://dx.doi.org/10.1016/j.molbrainres.2005.02.016
PMid:15950766
Pinto GR, Yoshioka FK, Silva RL, Clara CA, et al. (2008). Prognostic value of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms and the susceptibility to gliomas in individuals from Southeast Brazil. Genet. Mol. Res. 7: 207-216.
http://dx.doi.org/10.4238/vol7-1gmr415
PMid:18393224
Rajaraman P, Wang SS, Rothman N, Brown MM, et al. (2007). Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol. Biomarkers Prev. 16: 1655-1661.
http://dx.doi.org/10.1158/1055-9965.EPI-07-0314
PMid:17684142
Shete S, Hosking FJ, Robertson LB, Dobbins SE, et al. (2009). Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet. 41: 899-904.
http://dx.doi.org/10.1038/ng.407
PMid:19578367
Suzuki SO and Iwaki T (2000). Amplification and overexpression of mdm2 gene in ependymomas. Mod. Pathol. 13: 548-553.
http://dx.doi.org/10.1038/modpathol.3880095
PMid:10824927
Tsuiki H, Nishi T, Takeshima H, Yano S, et al. (2007). Single nucleotide polymorphism 309 affects murin-double-minute 2 protein expression but not glioma tumorigenesis. Neurol. Med. Chir. 47: 203-208.
http://dx.doi.org/10.2176/nmc.47.203
Wang LE, Bondy ML, Shen H, El-Zein R, et al. (2004). Polymorphisms of DNA repair genes and risk of glioma. Cancer Res. 64: 5560-5563.
http://dx.doi.org/10.1158/0008-5472.CAN-03-2181
PMid:15313891
Wrensch M, Fisher JL, Schwartzbaum JA, Bondy M, et al. (2005). The molecular epidemiology of gliomas in adults. Neurosurg. Focus 19: E5.
http://dx.doi.org/10.3171/foc.2005.19.5.6
PMid:16398469
Wrensch M, Jenkins RB, Chang JS, Yeh RF, et al. (2009). Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat. Genet. 41: 905-908.
http://dx.doi.org/10.1038/ng.408
PMid:19578366 PMCid:2923561
Yang M, Guo Y, Zhang X, Miao X, et al. (2007). Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer. Carcinogenesis 28: 1996-2001.
http://dx.doi.org/10.1093/carcin/bgm168
PMid:17638920
Zhou Y, Li N, Zhuang W, Liu GJ, et al. (2007). P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int. J. Cancer 121: 1481-1486.
http://dx.doi.org/10.1002/ijc.22833
PMid:17546594
“Genetic algorithm-based efficient feature selection for classification of pre-miRNAs”, vol. 10, pp. 588-603, 2011.
, Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
doi:10.1016/S0092-8674(04)00045-5
Batuwita R and Palade V (2009). microPred: effective classification of pre-miRNAs for human miRNA gene prediction. Bioinformatics 25: 989-995.
doi:10.1093/bioinformatics/btp107
PMid:19233894
Berezikov E, Guryev V, van de Belt J, Wienholds E, et al. (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21-24.
doi:10.1016/j.cell.2004.12.031
PMid:15652478
Bushati N and Cohen SM (2007). microRNA functions. Annu. Rev. Cell Dev. Biol. 23: 175-205.
doi:10.1146/annurev.cellbio.23.090506.123406
PMid:17506695
Chang DT, Wang CC and Chen JW (2008). Using a kernel density estimation based classifier to predict species-specific microRNA precursors. BMC Bioinformatics 9 (Suppl 12): S2.
doi:10.1186/1471-2105-9-S12-S2
PMid:19091019 PMCid:2638167
Chatterjee S and Grosshans H (2009). Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 461: 546-549.
doi:10.1038/nature08349
PMid:19734881
Fera D, Kim N, Shiffeldrim N, Zorn J, et al. (2004). RAG: RNA-As-Graphs web resource. BMC Bioinformatics 5: 88.
doi:10.1186/1471-2105-5-88
PMid:15238163 PMCid:471545
Freyhult E, Gardner PP and Moulton V (2005). A comparison of RNA folding measures. BMC Bioinformatics 6: 241.
doi:10.1186/1471-2105-6-241
PMid:16202126 PMCid:1274297
Gan HH, Fera D, Zorn J, Shiffeldrim N, et al. (2004). RAG: RNA-As-Graphs database - concepts, analysis, and features. Bioinformatics 20: 1285-1291.
doi:10.1093/bioinformatics/bth084
PMid:14962931
Griffiths-Jones S, Saini HK, van Dongen S and Enright AJ (2008). miRBase: tools for microRNA genomics. Nucleic Acids Res. 36: D154-D158.
doi:10.1093/nar/gkm952
PMid:17991681 PMCid:2238936
Hofacker IL, Fontana W, Stadler PF, Bonhoeffer LS, et al. (1994). Fast folding and comparison of RNA secondary structures. Monatshefte fur Chemie/Chemical Monthly 125: 167-188.
Jiang P, Wu H, Wang W, Ma W, et al. (2007). MiPred: classification of real and pseudo microRNA precursors using random forest prediction model with combined features. Nucleic Acids Res. 35: W339-W344.
doi:10.1093/nar/gkm368
PMid:17553836 PMCid:1933124
Moulton V, Zuker M, Steel M, Pointon R, et al. (2000). Metrics on RNA secondary structures. J. Comput. Biol. 7: 277-292.
doi:10.1089/10665270050081522
PMid:10890402
Nam JW, Shin KR, Han J, Lee Y, et al. (2005). Human microRNA prediction through a probabilistic co-learning model of sequence and structure. Nucleic Acids Res. 33: 3570-3581.
doi:10.1093/nar/gki668
PMid:15987789 PMCid:1159118
Ng KL and Mishra SK (2007). De novo SVM classification of precursor microRNAs from genomic pseudo hairpins using global and intrinsic folding measures. Bioinformatics 23: 1321-1330.
doi:10.1093/bioinformatics/btm026
PMid:17267435
Quinlan JR (1993). C4.5: Programs for Machine Learning. Morgan Kaufmann Publishers, San Mateo.
Schultes EA, Hraber PT and LaBean TH (1999). Estimating the contributions of selection and self-organization in RNA secondary structure. J. Mol. Evol. 49: 76-83.
doi:10.1007/PL00006536
PMid:10368436
Seffens W and Digby D (1999). mRNAs have greater negative folding free energies than shuffled or codon choice randomized sequences. Nucleic Acids Res. 27: 1578-1584.
doi:10.1093/nar/27.7.1578
PMid:10075987 PMCid:148359
Sewer A, Paul N, Landgraf P, Aravin A, et al. (2005). Identification of clustered microRNAs using an ab initio prediction method. BMC Bioinformatics 6: 267.
doi:10.1186/1471-2105-6-267
PMid:16274478 PMCid:1315341
Xue C, Li F, He T, Liu GP, et al. (2005). Classification of real and pseudo microRNA precursors using local structure-sequence features and support vector machine. BMC Bioinformatics 6: 310.
doi:10.1186/1471-2105-6-310
PMid:16381612 PMCid:1360673
Yousef M, Nebozhyn M, Shatkay H, Kanterakis S, et al. (2006). Combining multi-species genomic data for microRNA identification using a naive Bayes classifier. Bioinformatics 22: 1325-1334.
doi:10.1093/bioinformatics/btl094
PMid:16543277
Yousef M, Jung S, Showe LC and Showe MK (2008). Learning from positive examples when the negative class is undetermined - microRNA gene identification. Algorithms Mol. Biol. 3: 2.
doi:10.1186/1748-7188-3-2
PMid:18226233 PMCid:2248178
Zhang BH, Pan XP, Cox SB, Cobb GP, et al. (2006). Evidence that miRNAs are different from other RNAs. Cell Mol. Life Sci. 63: 246-254.
doi:10.1007/s00018-005-5467-7
PMid:16395542
“Novel NKX2-5 mutations responsible for congenital heart disease”, vol. 10, pp. 2905-2915, 2011.
, Akazawa H and Komuro I (2005). Cardiac transcription factor Csx/Nkx2-5: its role in cardiac development and diseases. Pharmacol. Ther. 107: 252-268.
http://dx.doi.org/10.1016/j.pharmthera.2005.03.005
Benson DW, Silberbach GM, Kavanaugh-McHugh A, Cottrill C, et al. (1999). Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J. Clin. Invest. 104: 1567-1573.
http://dx.doi.org/10.1172/JCI8154
PMid:10587520 PMCid:409866
Biben C, Weber R, Kesteven S, Stanley E, et al. (2000). Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ. Res. 87: 888-895.
PMid:11073884
Briggs LE, Takeda M, Cuadra AE, Wakimoto H, et al. (2008). Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects. Circ. Res. 103: 580-590.
http://dx.doi.org/10.1161/CIRCRESAHA.108.171835
PMid:18689573 PMCid:2590500
Ching YH, Ghosh TK, Cross SJ, Packham EA, et al. (2005). Mutation in myosin heavy chain 6 causes atrial septal defect. Nat. Genet. 37: 423-428.
http://dx.doi.org/10.1038/ng1526
PMid:15735645
Elliott DA, Kirk EP, Yeoh T, Chandar S, et al. (2003). Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J. Am. Coll. Cardiol. 41: 2072-2076.
http://dx.doi.org/10.1016/S0735-1097(03)00420-0
Garg V, Kathiriya IS, Barnes R, Schluterman MK, et al. (2003). GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447.
http://dx.doi.org/10.1038/nature01827
PMid:12845333
Garg V, Muth AN, Ransom JF, Schluterman MK, et al. (2005). Mutations in NOTCH1 cause aortic valve disease. Nature 437: 270-274.
http://dx.doi.org/10.1038/nature03940
PMid:16025100
Grow MW and Krieg PA (1998). Tinman function is essential for vertebrate heart development: elimination of cardiac differentiation by dominant inhibitory mutants of the tinman-related genes, XNkx2-3 and XNkx2-5. Dev. Biol. 204: 187-196.
http://dx.doi.org/10.1006/dbio.1998.9080
PMid:9851852
Hirayama-Yamada K, Kamisago M, Akimoto K, Aotsuka H, et al. (2005). Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am. J. Med. Genet. A 135: 47-52.
http://dx.doi.org/10.1002/ajmg.a.30684
PMid:15810002
Hosoda T, Komuro I, Shiojima I, Hiroi Y, et al. (1999). Familial atrial septal defect and atrioventricular conduction disturbance associated with a point mutation in the cardiac homeobox gene CSX/NKX2-5 in a Japanese patient. Jpn. Circ. J. 63: 425-426.
http://dx.doi.org/10.1253/jcj.63.425
PMid:10943630
Jenkins KJ, Correa A, Feinstein JA, Botto L, et al. (2007). Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 2995-3014.
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.183216
PMid:17519397
Kasahara H and Benson DW (2004). Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies. Cardiovasc. Res. 64: 40-51.
http://dx.doi.org/10.1016/j.cardiores.2004.06.004
PMid:15364612
Kasahara H, Lee B, Schott JJ, Benson DW, et al. (2000). Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J. Clin. Invest. 106: 299-308.
http://dx.doi.org/10.1172/JCI9860
PMid:10903346 PMCid:314312
Kasahara H, Wakimoto H, Liu M, Maguire CT, et al. (2001). Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein. J. Clin. Invest. 108: 189-201.
PMid:11457872 PMCid:203028
Kodo K, Nishizawa T, Furutani M, Arai S, et al. (2009). GATA6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc Natl. Acad. Sci U. S. A. 106: 13933-13938.
http://dx.doi.org/10.1073/pnas.0904744106
PMid:19666519 PMCid:2728998
Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, et al. (1997). Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat. Genet. 15: 21-29.
http://dx.doi.org/10.1038/ng0197-21
PMid:8988164
Lloyd-Jones D, Adams R, Carnethon M, De Simone G, et al. (2009). Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-181.
http://dx.doi.org/10.1161/CIRCULATIONAHA.108.191261
PMid:19075105
Lyons I, Parsons LM, Hartley L, Li R, et al. (1995). Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev. 9: 1654-1666.
http://dx.doi.org/10.1101/gad.9.13.1654
Matsson H, Eason J, Bookwalter CS, Klar J, et al. (2008). Alpha-cardiac actin mutations produce atrial septal defects. Hum. Mol. Genet. 17: 256-265.
http://dx.doi.org/10.1093/hmg/ddm302
PMid:17947298
Nora JJ and Nora AH (1976). Recurrence risks in children having one parent with a congenital heart disease. Circulation 53: 701-702.
PMid:1253394
Pashmforoush M, Lu JT, Chen H, Amand TS, et al. (2004). Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117: 373-386.
http://dx.doi.org/10.1016/S0092-8674(04)00405-2
Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, et al. (2007). Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115: 3015-3038.
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.183056
PMid:17519398
Prall OW, Menon MK, Solloway MJ, Watanabe Y, et al. (2007). An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 128: 947-959.
http://dx.doi.org/10.1016/j.cell.2007.01.042
PMid:17350578 PMCid:2092439
Razzaque MA, Nishizawa T, Komoike Y, Yagi H, et al. (2007). Germline gain-of-function mutations in RAF1 cause Noonan syndrome. Nat. Genet. 39: 1013-1017.
http://dx.doi.org/10.1038/ng2078
PMid:17603482
Reamon-Buettner SM and Borlak J (2004). Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease. J. Med. Genet. 41: 684-690.
http://dx.doi.org/10.1136/jmg.2003.017483
PMid:15342699 PMCid:1735891
Roberts AE, Araki T, Swanson KD, Montgomery KT, et al. (2007). Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat. Genet. 39: 70-74.
http://dx.doi.org/10.1038/ng1926
PMid:17143285
Rodriguez-Viciana P, Tetsu O, Tidyman WE, Estep AL, et al. (2006). Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311: 1287-1290.
http://dx.doi.org/10.1126/science.1124642
PMid:16439621
Sarkozy A, Conti E, Neri C, D’Agostino R, et al. (2005). Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J. Med. Genet. 42: e16.
http://dx.doi.org/10.1136/jmg.2004.026740
PMid:15689439 PMCid:1735979
Schott JJ, Benson DW, Basson CT, Pease W, et al. (1998). Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281: 108-111.
http://dx.doi.org/10.1126/science.281.5373.108
PMid:9651244
Shiojima I, Komuro I, Inazawa J, Nakahori Y, et al. (1995). Assignment of cardiac homeobox gene CSX to human chromosome 5q34. Genomics 27: 204-206.
http://dx.doi.org/10.1006/geno.1995.1027
PMid:7665173
Stallmeyer B, Fenge H, Nowak-Gottl U and Schulze-Bahr E (2010). Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease. Clin. Genet. 78: 533-540.
http://dx.doi.org/10.1111/j.1399-0004.2010.01422.x
PMid:20456451
Tanaka M, Chen Z, Bartunkova S, Yamasaki N, et al. (1999). The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126: 1269-1280.
PMid:10021345